Michael Ferrick, MD - Medicare Orthopaedic Surgery in Amherst, NY

Michael Ferrick, MD is a medicare enrolled "Orthopaedic Surgery" physician in Amherst, New York. His current practice location is 4949 Harlem Rd, Amherst, New York. You can reach out to his office (for appointments etc.) via phone at (716) 204-3251.

Michael Ferrick is licensed to practice in New York (license number 206790) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1053382564.

Contact Information

Michael Ferrick, MD
4949 Harlem Rd,
Amherst, NY 14226-2500
(716) 204-3251
(716) 204-3269



Physician's Profile

Full NameMichael Ferrick
GenderMale
SpecialityOrthopaedic Surgery
Location4949 Harlem Rd, Amherst, New York
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1053382564
  • Provider Enumeration Date: 02/01/2006
  • Last Update Date: 04/17/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 6002875374
  • Enrollment ID: I20041004000855

Medical Identifiers

Medical identifiers for Michael Ferrick such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053382564NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207X00000XOrthopaedic Surgery 206790 (New York)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Michael Ferrick allows following entities to bill medicare on his behalf.
Entity NameKaleida Health
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366473183
PECOS PAC ID: 7810805280
Enrollment ID: O20031105000212

News Archive

Fourth-quarter and full-year 2009 results announced by Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the fourth quarter and full year ended December 31, 2009.

Mayer Laboratories acquires Today Sponge contraceptive distribution rights

Mayer Laboratories, Inc., a marketer and distributor of high-quality contraceptive and other reproductive healthcare products, has announced that it has signed an agreement with Alvogen Group for the exclusive distribution rights of the Today Sponge for the United States, Europe and Canada.

NTU launches new CryoEM lab equipped with advanced cryo transmission electron microscope

Nanyang Technological University (NTU) today launched a new electron microscopy lab led by world renowned scientist Professor Daniela Rhodes. Named the NTU Cryo-Electron Microscopy Laboratory, it is also the world's first university research facility to be equipped with an advanced cryo transmission electron microscope fitted with the latest detector/camera ten times more sensitive than a regular electron microscopy camera.

Advaxis announces full exercise of over-allotment option granted to underwriters

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.

Protective effects of ischemic preconditioning on focal cerebral infarction linked with upregulation of VEGF

Neuroprotection by ischemic preconditioning has been confirmed by many studies, but the precise mechanism remains unclear.

Read more Medical News

› Verified 6 days ago

Entity NameUniversity Orthopaedic Services Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578599866
PECOS PAC ID: 7810983004
Enrollment ID: O20040422001292

News Archive

Fourth-quarter and full-year 2009 results announced by Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the fourth quarter and full year ended December 31, 2009.

Mayer Laboratories acquires Today Sponge contraceptive distribution rights

Mayer Laboratories, Inc., a marketer and distributor of high-quality contraceptive and other reproductive healthcare products, has announced that it has signed an agreement with Alvogen Group for the exclusive distribution rights of the Today Sponge for the United States, Europe and Canada.

NTU launches new CryoEM lab equipped with advanced cryo transmission electron microscope

Nanyang Technological University (NTU) today launched a new electron microscopy lab led by world renowned scientist Professor Daniela Rhodes. Named the NTU Cryo-Electron Microscopy Laboratory, it is also the world's first university research facility to be equipped with an advanced cryo transmission electron microscope fitted with the latest detector/camera ten times more sensitive than a regular electron microscopy camera.

Advaxis announces full exercise of over-allotment option granted to underwriters

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.

Protective effects of ischemic preconditioning on focal cerebral infarction linked with upregulation of VEGF

Neuroprotection by ischemic preconditioning has been confirmed by many studies, but the precise mechanism remains unclear.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael Ferrick is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Michael Ferrick, MD
4225 Genesee St,
Cheektowaga, NY 14225-1994

Ph: (716) 906-5908
Michael Ferrick, MD
4949 Harlem Rd,
Amherst, NY 14226-2500

Ph: (716) 204-3251

News Archive

Fourth-quarter and full-year 2009 results announced by Vanda Pharmaceuticals

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the fourth quarter and full year ended December 31, 2009.

Mayer Laboratories acquires Today Sponge contraceptive distribution rights

Mayer Laboratories, Inc., a marketer and distributor of high-quality contraceptive and other reproductive healthcare products, has announced that it has signed an agreement with Alvogen Group for the exclusive distribution rights of the Today Sponge for the United States, Europe and Canada.

NTU launches new CryoEM lab equipped with advanced cryo transmission electron microscope

Nanyang Technological University (NTU) today launched a new electron microscopy lab led by world renowned scientist Professor Daniela Rhodes. Named the NTU Cryo-Electron Microscopy Laboratory, it is also the world's first university research facility to be equipped with an advanced cryo transmission electron microscope fitted with the latest detector/camera ten times more sensitive than a regular electron microscopy camera.

Advaxis announces full exercise of over-allotment option granted to underwriters

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.

Protective effects of ischemic preconditioning on focal cerebral infarction linked with upregulation of VEGF

Neuroprotection by ischemic preconditioning has been confirmed by many studies, but the precise mechanism remains unclear.

Read more News

› Verified 6 days ago


Orthopaedic Surgery Doctors in Amherst, NY

Jeremy Paul Doak, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 4949 Harlem Rd, Amherst, NY 14226
Phone: 716-204-3251    Fax: 716-204-3269
Dr. Daniel Vincent Vargo, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3925 Sheridan Dr, Amherst, NY 14226
Phone: 716-250-9999    
Marc S Fineberg, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 4949 Harlem Rd, 2nd Floor, Amherst, NY 14226
Phone: 716-204-3257    
Lisa A Daye, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3925 Sheridan Drive, Suite 100, Amherst, NY 14226
Phone: 716-250-9999    Fax: 716-250-4177
Nicholas Jon-paul Violante, DO
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3925 Sheridan Dr, Amherst, NY 14226
Phone: 716-250-9999    
Dr. Kory Benjamin Reed, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3925 Sheridan Dr, Amherst, NY 14226
Phone: 716-250-9999    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.